Navigation Links
Heart Drug Digoxin Tied to Higher Death Risk for Some Patients
Date:11/28/2012

WEDNESDAY, Nov. 28 (HealthDay News) -- The widely used heart drug digoxin is associated with an increased risk of death in people with the common heart rhythm disorder know as atrial fibrillation, a new study finds.

Researchers analyzed data from more than 4,000 patients with atrial fibrillation and found that digoxin was associated with a 41 percent increased risk of death from all causes, a 35 percent increased risk of death from cardiovascular causes, and a 61 percent increased risk of death from problems with the rate and rhythm of the heartbeat.

The findings mean that among patients with atrial fibrillation who take taking digoxin -- compared to those not taking digoxin -- one additional patient out of six will die from any cause over five years, one additional patient out of eight will die from cardiovascular causes, and one additional patient out of 16 will die from arrhythmias, the study authors said.

The study, led by Samy Claude Elayi, an associate professor of medicine at the Gill Heart Institute at the University of Kentucky, was published online Nov. 28 in the European Heart Journal.

Digoxin is found naturally in the foxglove plant, from which it is extracted. The drug helps the heart beat more strongly and with a more regular rhythm and is commonly used in both atrial fibrillation patients and heart failure patients. However, while the use of digoxin has been widely studied in heart failure patients, there's been a lack of data about its use in patients with the irregular heartbeat, according to the study authors.

They said their findings call into the question the widespread use of digoxin in atrial fibrillation patients.

"These findings mean that physicians should try to control a patient's heart rate by using alternatives as a first line, such as beta-blockers or calcium blockers; if digoxin is used, use a low dose with careful clinical follow-up, evaluate potential drug interactions when starting new medications, and monitor digoxin levels," the authors said "Patients should be aware of potential toxicity and see their physicians immediately in specific clinical situations, for instance if they experience palpitations or syncope (fainting), as those may precede arrhythmic death," they added.

The mechanism by which digoxin increased the risk of death in atrial fibrillation patients is unclear. And while the study noted an association between digoxin use and increased death risk in these patients, it could not prove a cause-and-effect relationship.

"Deaths from classic cardiovascular causes, whether due to arrhythmia or not, can partly but not entirely explain [the relationship]," Elayi and his colleagues wrote. "This suggests there must be some additional mechanism that remains to be identified."

More information

The U.S. National Heart, Lung, and Blood Institute has more about atrial fibrillation.

-- Robert Preidt

SOURCE: European Heart Journal, news release, Nov. 28, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Heart Failure Drugs Put to the Test
2. Overactive Thyroid May Raise Risk for Common Irregular Heartbeat
3. High Blood Pressure During Pregnancy Tied to Later Heart Trouble
4. Tips for Holiday Heartburn Relief
5. Routine Checkups Dont Cut Cancer, Heart Deaths: Study
6. Unemployed at Higher Risk for Heart Attack?
7. Regular Exercise May Help Seniors Stave Off Heart Failure
8. Umbilical cord cells outperform bone marrow cells in repairing damaged hearts
9. Early Menstruation Tied to Factors That Raise Heart Disease Risk
10. Herceptin May Carry Higher Heart Risks for Women Than Thought
11. Heart failure in older breast cancer patients linked to medication
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Heart Drug Digoxin Tied to Higher Death Risk for Some Patients
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) ... a collection of specialty vendors and unique items from across the nation, this holiday-themed ... and wellness services offered by the VNA. The boutique will be open Saturday, ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
Breaking Medicine News(10 mins):
(Date:10/5/2017)... , Oct. 5, 2017  In response to ... Oral and Maxillofacial Surgeons (AAOMS) released prescribing recommendations ... to be used as a first-line therapy to ... Recognizing the value ... White Paper "Opioid Prescribing: Acute and Postoperative Pain ...
(Date:10/4/2017)... OBP Medical , a leading ... today announced regulatory approval from Brazil,s ... Nacional de Vigilância Sanitária (ANVISA)) to market ... with integrated LED light source and smoke evacuation ... of a tissue pocket or cavity during surgical ...
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
Breaking Medicine Technology: